Navigation Links
National Western Life Announces 2008 Fourth Quarter and 2008 Earnings
Date:3/9/2009

AUSTIN, Texas, March 9 /PRNewswire-FirstCall/ -- Ross R. Moody, President of National Western Life Insurance Company (Nasdaq: NWLI), announced today fourth quarter 2008 consolidated net earnings of $10.9 million, or $3.06 per diluted Class A common share, compared with consolidated net earnings of $29.2 million, or $8.22 per diluted Class A common share, for the fourth quarter of 2007. For the year ended December 31, 2008, the Company reported consolidated net earnings of $33.6 million, or $9.48 per diluted Class A common share, compared with $85.4 million, or $23.95 per diluted Class A common share, a year ago. The Company's book value per share was $271.99.

Net earnings for the quarter and year ended December 31, 2008 included after-tax investment losses of $2.8 million and $17.0 million, or $0.79 and $4.80 per diluted Class A share, respectively. The after-tax investment losses were substantially the result of other-than-temporary impairments on bond holdings in which the fair values of securities declined significantly below their book value to the Company. Generally accepted accounting principles (GAAP) require that securities be written down in such situations even if the Company has the intent to hold the securities to maturity. Mr. Moody indicated that the Company's investment losses were a reflection of the current economic crisis. "We are fortunate to incur minimal investment losses on a $6 billion investment portfolio, particularly in light of what other life insurers have been reporting in their year-end earnings releases. The financial markets have become extremely volatile and illiquid which combined with stringent GAAP requirements make it difficult to avoid substantial investment losses," Mr. Moody stated.

Operating revenues, excluding realized investment gains (losses) and realized and unrealized gains (losses) on
'/>"/>

SOURCE National Western Life Insurance Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... More states are passing legislation permitting or requiring schools ... child having a severe allergic reaction. Epinephrine auto-injectors ... that can lead to throat swelling, breathing difficulties, a ... In people with severe allergies to certain foods, ... certain drugs, anaphylaxis can occur within moments of exposure ...
(Date:9/19/2014)... Wisconsin (MCW) scientists has identified a new gene associated with ... humans. The findings are published in the September issue of ... Ph.D., associate professor of pediatrics at MCW and a researcher ... study and is the corresponding author of the paper. , ... in which a variant was associated with fasting glucose levels ...
(Date:9/19/2014)... September 19, 2014 BCC Research reveals ... AND GLOBAL MARKETS , the global market for human ... billion by 2018, with a five-year compound annual growth ... is growing at a steady 3.8% CAGR. , Given ... lower sales, coupled with the incidence of increasing mortality ...
(Date:9/19/2014)... NY (PRWEB) September 19, 2014 Ticket ... presale tickets for her 2015 “Honeymoon” Tour. This ... ARIANA-2015 for additional savings at the checkout. , Ariana Grande ... MO (Independence Event Center) , Feb. 28, 2015: Milwaukee, WI ... MN (Xcel Energy Center) , March 03, 2015: Chicago, IL ...
(Date:9/19/2014)... from the wonder material graphene has been used to ... cancer. , The biosensor has been shown to ... tests currently in use, and was able to provide ... possibility of a rapid, point-of-care diagnostic tool for patients. ... in IOP Publishing,s journal 2D Materials . , ...
Breaking Medicine News(10 mins):Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 2Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 3Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 4Health News:Graphene sensor tracks down cancer biomarkers 2
... and public campaigner, has made known the fact that she ... , Dame Anita known worldwide for her company, ... was infected with the virus in 1971 via infected blood, ... businesswoman who is well known for her indefatigable campaigning has ...
... Organization (PAHO) are working with health authorities in Paraguay ... has affected a// number of communities throughout the nation ... America. ,PAHO officials warn that the entire ... prepare for what promises to be a "difficult year" ...
... A recent study by scientists at University of Wisconsin-Madison ... hear better. ,Led by Ruth Litovsky, an ... suggests that deaf children who have a cochlear implant ... use both implants instead of one. Children with two ...
... treatment for an abdominal aortic aneurysm, a weak spot ... time. If the vessel ruptures suddenly before surgery to ... scientists say they have identified a key enzyme that ... growth of aneurysms. Their finding raises hopes for developing ...
... omega-3 fatty acids on their own can alleviate depression, ... there is only limited evidence that they can relieve ... adds. ,Evidence from circumstantial research has suggested ... such as depression. And the findings have attracted widespread ...
... bottle-fed children, reveals a large, long term study, published// ahead ... ,Over 3000 children from 16 rural and urban areas ... of the Boyd Orr Study of Diet and Health in ... on 1414 people in their 60s and 70s, for whom ...
Cached Medicine News:Health News:Body Shop Founder’s New Project-against Hepatitis 2Health News:PAHO Urges Readiness for Dengue Outbreaks in 2007 2Health News:Cochlear Implants in Both Ears Enables Better Hearing 2Health News:Cochlear Implants in Both Ears Enables Better Hearing 3Health News:Enzyme Critical for Early Growth of Abdominal Aortic Aneurysms 2Health News:Enzyme Critical for Early Growth of Abdominal Aortic Aneurysms 3
(Date:9/19/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... ITCA 650 (continuous subcutaneous delivery of exenatide) in type ... the 50 th Annual Meeting of the European ... the open-label, phase 3 FREEDOM-HBL (high baseline) trial showed ... poorly controlled type 2 diabetes. The results were presented ...
(Date:9/18/2014)... , September 19, 2014 ... Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced the ... Market 2014-2018" report to their offering. ... Cytogenetics involves the study of chromosomes using ... functions of genes and chromosomes. It plays ...
(Date:9/18/2014)... -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for ... 30, 2014. Quarter Ended June 30, ... 2014 increased $492,000, or 18%, to $3.2 million from ... 2013, due primarily to an increase of $746,000 in ... largest customer, partially offset by an aggregate decrease in ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 2Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 4Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 5Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 6Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 7Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 8Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 9Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 10Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 11Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 12Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 13
... Carnegie Mellon University,s Bone Tissue Engineering Center ... limbs in combat. (Logo: http://photos.prnewswire.com/prnh/20020422/CMULOGO) ... Hollinger, director of the center, and Professor Krzysztof ... Department of Defense research grant to develop a ...
... Stanley M. Chesley of the Cincinnati, Ohio-based law firm of ... a major class action lawsuit against DePuy Orthopaedics, Inc. and ... Johnson and Johnson recently recalled over 90,000 ASR XL Acetabular ... causing patients to undergo hip replacement surgery. ...
Cached Medicine Technology:CMU's Bone Tissue Engineering Center Receives Defense Department Research Grant to Help Injured Soldiers 2
Reusable, stainless steel trephine with handle....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: